A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3
Literature
Read More
An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors
Literature
Read More
NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference
Press Release
Read More
An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors
Literature
Read More
The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression
Literature
Read More
NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019
Press Release
Read More